Abstract
We present in this paper a patient with a clinically intermediate form of mucolipidosis (ML). Lysosomal hydrolase activity in fibroblasts was normal and levels of these enzymes in culture media were not elevated. There was a striking elevation of several hydrolases in serum and a deficiency (15% of normal) of N-acetyl-glucosamine phosphotransferase in fibroblasts. Atypical electron microscopic findings were also observed.
There was no evidence of increased synthesis, slower turnover, unbalanced distribution or further changes in lysosomal enzymes. Phosphotransferase deficiency against endogenous β-glucosaminidase and the fact that the electrophoretic mobility of lysosomal enzymes was identical to that of ML II suggest that these enzymes are not phosphorylated. Hypotheses that could explain this atypical pathology are discussed.
Similar content being viewed by others
Abbreviations
- ML II:
-
mucolipidosis type II
- ML III:
-
mucolipidosis type III
- 4 MU:
-
4-methylum belliferone
- Con A:
-
concanavaline A
- Hex A:
-
hexosaminidase A
- HA:
-
our patient's initials
- PT:
-
N-acetylglucosamine-1-phosphotransferase
- Hex:
-
N-acetyl-β-glucosaminidase
References
Alexander D, Deeb M, Talj F (1986) Heterogeneity for phosphodiester glycosidase deficiency: a novel human mutation of lysosomal enzyme processing, Hum Genet 73:53–59
Ashwell G, Morell A (1974) The role of cell surface carbohydrates in hepatic recognition and transport of circulating glycoprotein. Adv Enzymol 41:99–128
Bach G, Bargal R, Cantz M (1979) I-cell disease deficiency of extracellular hydrolase phosphorylation. Biochem Biophys Res Commun 91:976–981
De Mars RJ, Leroy JG (1967) The remarkable cell culture from a human with Hurler's syndrome. In Vitro 2:107–112
Dreyfus JC, Poenaru L (1975) Le diagnostic enzymatique dans les maladies lysosomiales. Arch Fr Pédiatr 32:503–514
Fischer HD, Gonzales-Noriega A, Sly WS, Morre PJ (1980) Phosphomannosylenzyme receptors in rat liver. J Biol Chem 255:5069–5074
Galjaard H (1980) Genetic metabolic diseases. Elsevier North Holland Biomedical Press Amsterdam New York Oxford, p 818
Hasilik A, Neufeld EF (1980) Biosynthesis of lysosomal enzymes in fibroblasts. II. Phosphorylation of mannose residue. J Biol Chem 255:4946–4950
Hickman S, Neufeld EF (1972) A hypothesis for I-cell disease: defective hydrolases that do not enter lysosomes. Biochem Biophys Res Commun 49:992–999
Hoflack B, Kornfied S (1985) Lysosomal enzyme binding to mouse P 388 D1 macrophage membranes lacking the 215 KDa mannose 6 phosphate receptor. Evidence for the existence of a second mannose 6 Ph receptor. Proc Natl Acad Sci USA 82:4428–4430
Honey NK, Miller AL, Shows TB (1981) The mucolipidosis: identification by abnormal electrophoretic patterns of lysosomal hydrolases. Am J Med Genet 9:239–253
Honey NK, Mueller OT, Little LE, Miller AL, Shows TB (1982) Mucolipidosis III is genetically heterogeneous. Proc Natl Acad Sci USA 79:7420–7424
Kelly TE, Thomas GH, Taylor A, McKusick VA, Sly WS, Glaser JH, Robinow M, Luzzatti L, Espiritu C, Feingold M, Bull MJ, Ashenhurst EM, Yves EJ (1975) Mucolipidosis III. Clinical and laboratory findings. Johns Hopkins Med J 137:156–175
Lang L, Takahashi T, Lang J, Kornfeld S (1985) Lysosomal enzyme phosphorylation in human fibroblats. J Clin Invest 76:2191–2196
Leroy JG, De Mars RJ (1967) Mutant enzymatic and cytological phenotypes in cultured human fibroblasts. Science 157:804–806
Leroy JG, O'Brien JS (1976) Mucolipidosis II and III: different residual activity of β-galactosidase in cultured fibroblasts. Clin Genet 9:533–539
Leroy JG, Spranger JW, Feingold M, Opitz JM, Crocker AC (1971) I-cell disease: a clinical picture. J Pediatr 79:360–365
Leroy JG, Ho M, Mac Brinn MC, Zielke K, Jacob J, O'Brien JS (1972) I-cell disease: biochemical studies. Pediatr Res 6:752–757
Little LE, Muller T, Honey NK, Shows TB, Miller AL (1986) Heterogeneity of N-acetylglucosamine 1 phosphotransferase with-in mucolipidosis III. J Biol Chem 261:733–738
Lightbody J, Wiesmann U, Hadron B, Herschkowitz N (1971) I-cell disease: multiple lysosomal defect. Lancet I:451–452
McKusick VA (1972) Heritable disorders of connective tissue. Mosby, St Louis, p 646
Maroteaux P, Lamy M (1966) La pseudopolydystropie de Hurler. Presse Med 74:2889–2895
Miller AL, Kress RC, Stein R, Kinnon C, Kern H, Schneider JA, Harms E (1981) Properties of N-acetyl-β-D-hexosaminidase from isolated normal and I-cell lysosomes. J Biol Chem 256:9352–9362
Muller OT, Honey NK, Little LE (1983) Mucolipidosis II and III. The genetic relationships between two disorders of lysosomal enzyme. J Clin Invest 72:1016–1023
Okada S, Kato T, Oshima T, Yutaka T, Yabuuchi H (1983) Heterogenety in mucolipidosis II (I-cell disease). Clin Genet 23:155–159
Poenaru L, Dreyfus JC (1973) Electrophoretic study of hexosaminidases. C. Clin Chim Acta 43:439–441
Reitman ML, Kornfeld S (1981) Lysosomal enzyme targeting. J Biol Chem 256:4275–4281
Reitmann ML, Varki A, Kornfeld S (1981) Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in UDP-N-acetyl-glucosamine: glycoprotein N-acetyl-glucosaminyl-phosphotransferase activity. J Clin Invest 67:1574–1579
Shepherd U, Schleisinger R, Stahl P (1983) Receptor for lysosomal enzymes and glycoproteins. In: Kleinzeller A, Richard-Martin B (eds) Current topics in membranes transport, vol 18. Academic Pres, New York, pp 317–339
Shows TB, Mueller OT, Honey NC, Wizight CF (1982) Genetic heterogeneity of I-cell disease is demonstrated by complementation of lysosomal enzyme processing mutants. Am J Med Genet 12:343–353
Stahl PD, Gordon S (1982) Expression of the mannosyl-fucosyl receptor by macrophages and their hybrids. J Cell Biol 93:49–56
Tabas I, Kornfeld S (1980) Biosynthetic intermediates of β-glucuronidase containing high mannose oligosaccharides with blocked phosphate residues. J Biol Chem 255:6633–6639
Thomas GH, Miller CS, Toomey KE, Reynolds LW, Reitman ML, Varki A, Vannier A, Rosenboum KN, Bias WB, Schofield BH (1982) Two clonal cell populations (Mosaicism) in a 46 XY Male with Mucolipidosis II. An autosomal recessive disorder. Am J Hum Genet 34:611–622
Tondeur M, Vamos-Hurwitz E, Mockel-Pohl S, Dereune JP, Cremer N, Loeb H (1971) clinical biochemical and ultrastructural studies in a case of chondrodystrophy presenting the I-cell phenotype in tissue culture. J Pediatr 79:366–378
Vladutiu GD, Rattazzi MC (1975) Abnormal lysosomal hydrolases excreted by cultured fibroblasts in I-cell disease (mucolipidosis II). Biochem Biophys Res Commun 67:956–964
Vladutiu GD, Rattazzi MC (1981) Compartmental distribution of β-hexosaminidase isoenzymes in I-cell fibroblasts. Biochem J 196:657–662
Vaheed A, Hasilik A, Cantz M, Von Figura K (1982) Marked deficiency on N-acetylglucosamine-1-phosphotransferase in fibroblasts of patients with mucolipidosis III. Hoppe-Seylerl's Z Physiol Chem 363:169–178
Vaheed A, Pohlmann R, Hasilic A, Von Figura K, Von Elsen K, Leroy JG (1982) Deficiency of UDP-N-acetylglucosamine: lysosomal enzyme N-acetyl-glucosamine 1 phosphotransferase in organs of I-cell patients. Biochem Biophys Res Commun 105: 1052–1058
Wiesmann U, Varsela F, Herschkowitz N (1971) I-cell disease. Leakage of lysosomal enzymes into extracellular fluids. N Engl J Med 285:1091–1091
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Poenaru, L., Castelnau, L., Tome, F. et al. A variant of mucolipidosis. Eur J Pediatr 147, 321–327 (1988). https://doi.org/10.1007/BF00442708
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00442708